Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
148 |
|
| Actual shortage: | 3 (2%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (94%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (20%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2017-11-28 | 2018-01-08 | 30982 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2018-10-17 | 2018-12-18 | 64629 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2022-01-12 | 2022-03-04 | 152535 |
| TEGRETOL SUSPENSION | 100MG | SUSPENSION | Resolved | 2024-01-15 | 2024-02-22 | 216049 |
| MAXITROL | 1MG 6000UNIT 3.5MG | SUSPENSION | Resolved | 2018-11-23 | 2019-02-05 | 67487 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-04-11 | 2022-06-17 | 158484 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-10-25 | 2023-01-25 | 172560 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2019-10-25 | 2020-02-27 | 97281 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2020-05-05 | 2020-06-17 | 114093 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2022-09-29 | 2024-01-30 | 170485 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-27 | 54440 |
| AZARGA | 0.5% 1.0% | SUSPENSION | Resolved | 2020-02-04 | 2020-04-17 | 105259 |
| FLAREX | 0.1% | SUSPENSION | Resolved | 2017-07-13 | 2017-07-27 | 15722 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2018-10-23 | 2018-11-07 | 65471 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-01-25 | 2019-03-13 | 73545 |
| TRIESENCE | 40MG | SUSPENSION | Resolved | 2019-05-07 | 2020-09-08 | 83368 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| RITALIN 20MG | 20MG | TABLET | Discontinued | 2019-07-22 | 2019-08-01 | 89771 |
| LIORESAL D.S. TAB 20MG | 20MG | TABLET | Discontinued | 2020-01-10 | 2020-02-24 | 103075 |
| LIORESAL TAB 10MG | 10MG | TABLET | Discontinued | 2020-01-10 | 2020-07-10 | 103078 |
| RITALIN 10MG | 10MG | TABLET | Discontinued | 2022-02-08 | 2022-05-11 | 154449 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| VOLTAREN | 100MG | SUPPOSITORY | Discontinued | 2017-05-01 | 2017-11-02 | 8504 |
| ARZERRA | 100MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78215 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| LOPRESOR INJ 1.0MG/ML | 1MG | SOLUTION | Discontinued | 2019-04-05 | 2019-09-06 | 80607 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
| SANDOSTATIN | 200MCG | SOLUTION | Discontinued | 2022-02-08 | 2022-03-07 | 154429 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |